Comparison

CX-4945 (Silmitasertib)

Item no. DCC-DC7111-250mg
Manufacturer DCChemicals
CASRN 1009820-21-6
Amount 250 mg
Quantity options 100 mg 10 mM x 1 ml in DMSO 1 g 250 mg
Category
Type Inhibitors
Applications IC
Specific against other
Purity >98%
Smiles ClC1=C([H])C([H])=C([H])C(=C1[H])N([H])C1C2C([H])=C([H])N=C([H])C=2C2C([H])=C([H])C(C(=O)O[H])=C([H])C=2N=1
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias Silmitasertib,CX 4945,CX4945
Similar products 1009820-21-6
Available
Manufacturer - Applications
CX-4945 (Silmitasertib) is a potent and selective ATP-competitive small molecule protein kinase CK2 inhibitor with a Ki and an IC50 of 0.38 and 1 nM for recombinant human CK2α, respectively.
Storage Conditions
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Molecular Weight
349, 77
Note
For research only, not for human use.
Chemical name
5-(3-chlorophenylamino)benzo[c][2, 6]naphthyridine-8-carboxylicacid

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 250 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close